Skip to main content
Ahmet Hoke, MD, Neurology, Baltimore, MD, Johns Hopkins Hospital

AhmetHokeMDPhD

Neurology Baltimore, MD

Neuromuscular Medicine

Professor of Neurology, Johns Hopkins University School of Medicine; Director, Neuromuscular Division

Dr. Hoke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hoke's full profile

Already have an account?

Education & Training

  • University of Alberta
    University of AlbertaFellowship, Neuromuscular, 1997 - 1999
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 1994 - 1997
  • Case Western Reserve University
    Case Western Reserve UniversityPhD, Neuroscience, 1989 - 1994
  • The MetroHealth System/Case Western Reserve University
    The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1990 - 1992
  • Hacettepe University FOM
    Hacettepe University FOMClass of 1988

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1994 - 2024
  • OH State Medical License
    OH State Medical License 1992 - 1994
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

Press Mentions

  • Johns Hopkins Medicine Establishes Center Thanks to Gift from Merkin Family Foundation to Seek Better Understanding, Treatment of Damaging Nerve Disorder
    Johns Hopkins Medicine Establishes Center Thanks to Gift from Merkin Family Foundation to Seek Better Understanding, Treatment of Damaging Nerve DisorderApril 7th, 2021
  • Your Neurology Director Will See You Now…on Zoom
    Your Neurology Director Will See You Now…on ZoomSeptember 4th, 2020
  • Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB
    Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κBApril 9th, 2019
  • Join now to see all

Grant Support

  • The Foundation For Peripheral Neuropathy Research Symposium 2012National Institute Of Neurological Disorders And Stroke2012
  • "Peripheral Nerve Society Biannual Meeting 2011"National Institute Of Neurological Disorders And Stroke2011
  • Developmental CoreNational Institute Of Mental Health2011
  • HIV And Antiretroviral Toxic NeuropathyNational Institute Of Neurological Disorders And Stroke2007–2011
  • Mechanisms Of Glucose ToxicityNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Seahorse Xf-96 Analyzer For Non-Invasive Monitoring Of Mitochondrial FunctionNational Center For Research Resources2010
  • Peripheral Neurotoxicity By The HIV-1 Coat Protein GP120National Institute Of Neurological Disorders And Stroke2006–2007
  • An In Vitro Model Of Antiretroviral Toxic NeuropathyNational Institute Of Neurological Disorders And Stroke2002–2005

Professional Memberships

Other Languages

  • Turkish

Hospital Affiliations